-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CCTV news: The new version of the health insurance catalog will be implemented on January 1, 2020, many drug prices have dropped significantly, thanks to the benefits of the health insurance drug access negotiations.
25 experts participated in the 2019 National Health Insurance Drug Catalog Negotiations, which formed five expert groups that spent three days in intensive negotiations on 150 drugs, culminating in the negotiation of 97 drugs into the health insurance catalogue, of which 70 new drugs were added, an average decline of 60.7 percent.
for the first time to be included in the health insurance list, the price reduction 85% in the new list of 70 drugs, three drugs for the treatment of hepatitis C for the first time into the new version of the "National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drugs Directory", the average price reduction of more than 85%, covering all genotype patients.
this will greatly improve the treatment effect of nearly 10 million patients with hepatitis C in China, greatly reducing the economic burden.
a new edition of the catalog announced, on December 20, Kunming Third People's Hospital began to implement the new price of hepatitis C drugs, treatment of all hepatitis C genotype patients of the drug C-Tongsha, the original price from 70,000 to 13,000 yuan, less than 10 days, the hospital to treat hepatitis C drugs will soon be short.
this time included in the health insurance list to treat hepatitis C drugs, is a good medicine in the world, as long as the daily use of 1 capsule, continuous use of 12 weeks, hepatitis C virus cure rate of more than 98%.
survey shows that China's hepatitis C patients nearly 10 million cases, the world's largest number of hepatitis C patients.
the World Health Organization to eliminate viral hepatitis completely by 2030.
the reduction of drug prices will increase the availability of these drugs, greatly reduce the burden of drug use for patients, 2030 China's goal of eliminating hepatitis C will no longer be a dream.
.